Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
3650
Trial Sponsor
Clinical Trial Start Date
June 21, 2023
0Primary Completion Date
April 25, 2024
0Study Completion Date
May 23, 2024
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
Placebo0
S-3093090
Interventional Trial Phase
Phase 20
Official Name
A Phase 2, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Assess the Safety and Efficacy of S-309309 in Obese Adults0
Last Updated
October 31, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Investigator0
Participant0
Study summary
The primary objective of this study is to understand the efficacy of S-309309 on the body weight of obese adults.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
